Shares of Mettler-Toledo International, Inc. (NYSE:MTD) have been assigned a consensus rating of “Buy” from the nine ratings firms that are presently covering the stock, MarketBeat reports. Four analysts have rated the stock with a hold rating and five have issued a buy rating on the company. The average 12-month price objective among brokers that have updated their coverage on the stock in the last year is $591.00.

A number of equities research analysts have recently weighed in on MTD shares. Zacks Investment Research upgraded Mettler-Toledo International from a “hold” rating to a “buy” rating and set a $705.00 price target on the stock in a research note on Thursday, September 14th. Wells Fargo & Company upgraded Mettler-Toledo International from a “market perform” rating to an “outperform” rating in a research note on Wednesday, July 12th. Morgan Stanley restated an “equal weight” rating and set a $565.00 price target (up previously from $533.00) on shares of Mettler-Toledo International in a research note on Saturday, July 22nd. Bank of America Corporation lifted their target price on Mettler-Toledo International from $640.00 to $710.00 and gave the stock a “buy” rating in a report on Monday, October 9th. Finally, BidaskClub downgraded Mettler-Toledo International from a “strong-buy” rating to a “buy” rating in a report on Monday, July 31st.

In other Mettler-Toledo International news, Director Thomas P. Salice sold 890 shares of the business’s stock in a transaction that occurred on Thursday, September 7th. The stock was sold at an average price of $611.00, for a total value of $543,790.00. Following the completion of the transaction, the director now directly owns 62,437 shares of the company’s stock, valued at $38,149,007. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, insider William P. Donnelly sold 2,845 shares of the business’s stock in a transaction that occurred on Thursday, August 3rd. The shares were sold at an average price of $576.92, for a total value of $1,641,337.40. Following the completion of the transaction, the insider now directly owns 2,345 shares of the company’s stock, valued at $1,352,877.40. The disclosure for this sale can be found here. Insiders sold 27,356 shares of company stock valued at $16,150,829 over the last three months. 5.20% of the stock is currently owned by corporate insiders.

A number of large investors have recently made changes to their positions in the business. Aperio Group LLC lifted its holdings in Mettler-Toledo International by 6.2% in the third quarter. Aperio Group LLC now owns 18,744 shares of the medical instruments supplier’s stock valued at $11,737,000 after acquiring an additional 1,101 shares during the period. First Trust Advisors LP raised its stake in shares of Mettler-Toledo International by 41.5% during the 3rd quarter. First Trust Advisors LP now owns 66,605 shares of the medical instruments supplier’s stock worth $41,705,000 after buying an additional 19,540 shares during the period. WESPAC Advisors LLC acquired a new position in shares of Mettler-Toledo International during the 3rd quarter worth approximately $693,000. APG Asset Management N.V. raised its stake in shares of Mettler-Toledo International by 888.1% during the 3rd quarter. APG Asset Management N.V. now owns 60,502 shares of the medical instruments supplier’s stock worth $37,884,000 after buying an additional 54,379 shares during the period. Finally, Oakbrook Investments LLC acquired a new position in shares of Mettler-Toledo International during the 3rd quarter worth approximately $1,565,000. 93.14% of the stock is owned by institutional investors.

ILLEGAL ACTIVITY NOTICE: “Mettler-Toledo International, Inc. (MTD) Given Average Rating of “Buy” by Brokerages” was originally reported by American Banking News and is owned by of American Banking News. If you are accessing this article on another site, it was stolen and republished in violation of US and international trademark & copyright laws. The original version of this article can be read at https://www.americanbankingnews.com/2017/10/25/mettler-toledo-international-inc-mtd-given-average-rating-of-buy-by-brokerages.html.

Mettler-Toledo International (NYSE MTD) traded down 0.59% during trading on Wednesday, reaching $665.43. 116,350 shares of the company’s stock traded hands. The firm has a market cap of $17.08 billion, a price-to-earnings ratio of 40.92 and a beta of 1.11. The company has a 50 day moving average of $640.64 and a 200 day moving average of $588.20. Mettler-Toledo International has a one year low of $395.61 and a one year high of $672.69.

Mettler-Toledo International (NYSE:MTD) last issued its quarterly earnings results on Thursday, July 27th. The medical instruments supplier reported $3.92 earnings per share for the quarter, topping the Zacks’ consensus estimate of $3.89 by $0.03. Mettler-Toledo International had a return on equity of 95.28% and a net margin of 16.60%. The business had revenue of $653.70 million for the quarter, compared to analyst estimates of $646.68 million. During the same quarter in the previous year, the firm earned $3.22 earnings per share. The company’s revenue was up 7.5% on a year-over-year basis. Equities research analysts predict that Mettler-Toledo International will post $17.38 EPS for the current year.

Mettler-Toledo International Company Profile

Mettler-Toledo International Inc is a supplier of precision instruments and services. The Company operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations and Other. The Company manufactures weighing instruments for use in laboratory, industrial, packaging, logistics and food retailing applications.

Analyst Recommendations for Mettler-Toledo International (NYSE:MTD)

Receive News & Ratings for Mettler-Toledo International Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mettler-Toledo International Inc. and related companies with MarketBeat.com's FREE daily email newsletter.